Gut microbiota in patients with sarcopenia: a systematic review and meta-analysis
Frontiers in Microbiology · 22.01.2025 · 16
DOI: 10.3389/fmicb.2025.1513253 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Microbiology, online erschienen am 22.01.2025. Verfasst von Guangning Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Qingdao Hospital, University of Health and Rehabilitation Sciences, Qingdao, China. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Intestinal dysbiosis was considered a pivotal pathological mechanism underlying sarcopenia. Despite the fervor surrounding research in this domain, substantial controversy persists regarding the obtained outcomes.
Objective
To systematically summarized the disparities in gut microbiota composition between the group afflicted by sarcopenia and non-sarcopenia controls.
Methods
PubMed, Medline, CINAHL, EMBASE, Scopus, Web of Science and Google Scholer, Cochrane Library and gray literature sources were systematically searched for in randomized controlled trials. Meta-analysis and random-effects meta-regression were conducted using Rev. Man 5.3. Overall effect was measured using Hedges’s g and determined using Z-statistics. Cochran’s Q test and I 2 were used to investigate heterogeneity. The Newcastle-Ottawa Scale was used to assess overall quality of evidence.
Results
Ten studies, including 421 cases of sarcopenia and 1,642 cases of controls, were included in the meta-analysis. Patients with sarcopenia showed significantly reduced gut microbiota in α diversity, and β diversity was significantly different in 8/9 of included studies. We also found more abundance of phylum Proteobacteria and genus Escherichia-Shigella , and less abundance of phylum Firmicutes and genus Faecalibacterium , Prevotella 9 , Blautia in the sarcopenia group.
Conclusion
The gut microbiota composition in patients with sarcopenia has undergone alterations, serving as a fundamental reference for further investigation into the potential pathogenic mechanisms and treatment strategies for sarcopenia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Qingdao Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
- Reproductive Medicine Center, Women and Children's Hospital, Qingdao University, Qingdao, China.
- Department of Nursing, Qingdao Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
- Department of Clinical Research Center, Qingdao Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
Zitieren
APA
Wang, G., Li, Y., Liu, H., & Yu, X. (2025). Gut microbiota in patients with sarcopenia: a systematic review and meta-analysis. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1513253
Vancouver
Wang G, Li Y, Liu H, Yu X. Gut microbiota in patients with sarcopenia: a systematic review and meta-analysis. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1513253
BibTeX
@article{Wang2025,
author = {Wang, Guangning and Li, Yujie and Liu, Huisong and Yu, Xinjuan},
title = {Gut microbiota in patients with sarcopenia: a systematic review and meta-analysis},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1513253}
}
EUVIMED